Subscribe to RSS
DOI: 10.1055/s-0035-1549365
Microscopic Colitis (Lymphocytic and Collagenous), Eosinophilic Colitis, and Celiac Disease
Publication History
Publication Date:
25 May 2015 (online)
Abstract
Multiple tests are needed to diagnose a patient with noninfectious diarrhea. Some patients will be mistakenly labeled as diarrhea-predominant irritable bowel syndrome (IBS-D) because of nonspecific computed tomographic scans and grossly normal endoscopic findings. It is crucial to understand other less common pathologies to avoid these instances of misdiagnosis. This article focuses on microscopic colitis (MC), eosinophilic colitis (EC), and celiac disease. MC is an inflammatory condition of the colon that presents with two subtypes, only to be differentiated by histology. EC is a rare chronic inflammatory process. Depending on the extent of the disease, it can present with mild diarrhea, malabsorption, or at its worst, cause obstruction and perforation. Celiac disease affects the small bowel, but interestingly can present similarly to colitis. Both MC and EC respond to oral budesonide. Patients with celiac disease improve on gluten-free diets. These treatments are distinctly different from typical IBS-D care plans.
-
References
- 1 Pardi DS, Loftus Jr EV, Smyrk TC , et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56 (4) 504-508
- 2 Gentile NM, Khanna S, Loftus Jr EV , et al. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol 2014; 12 (5) 838-842
- 3 Storr MA. Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013. ISRN Gastroenterol 2013; 2013: 352718
- 4 Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease - microscopic colitis?. Aliment Pharmacol Ther 2012; 36 (2) 79-90
- 5 Jaskiewicz K, Rzepko R, Adrych K, Smoczyński M. Microscopic colitis in routine colonoscopies. Dig Dis Sci 2006; 51 (2) 241-244
- 6 Singh P, Das P, Jain AK , et al. Microscopic colitis in children with chronic diarrhea. J Pediatr Gastroenterol Nutr 2013; 57 (2) 240-244
- 7 Bohr J, Tysk C, Eriksson S, Abrahamsson H, Järnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39 (6) 846-851
- 8 Thorsen AJ. Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis. Clin Colon Rectal Surg 2007; 20 (1) 47-57
- 9 O'Toole A, Coss A, Holleran G , et al. Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population. Int J Colorectal Dis 2014; 29 (7) 799-803
- 10 Fernández-Bañares F, Salas A, Esteve M, Espinós J, Forné M, Viver JM. Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003; 98 (2) 340-347
- 11 Fernández-Bañares F, de Sousa MR, Salas A , et al; RECOMINA Project, GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa). Impact of current smoking on the clinical course of microscopic colitis. Inflamm Bowel Dis 2013; 19 (7) 1470-1476
- 12 Vigren L, Tysk C, Ström M , et al. Celiac disease and other autoimmune diseases in patients with collagenous colitis. Scand J Gastroenterol 2013; 48 (8) 944-950
- 13 Green PHR, Yang J, Cheng J, Lee AR, Harper JW, Bhagat G. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol 2009; 7 (11) 1210-1216
- 14 Stewart M, Andrews CN, Urbanski S, Beck PL, Storr M. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther 2011; 33 (12) 1340-1349
- 15 Fernández-Bañares F, de Sousa MR, Salas A , et al; RECOMINA Project, GETECCU Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa. Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis 2013; 19 (2) 411-417
- 16 Fernández-Bañares F, Esteve M, Espinós JC , et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007; 102 (2) 324-330
- 17 Thijs WJ, van Baarlen J, Kleibeuker JH, Kolkman JJ. Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. Neth J Med 2005; 63 (4) 137-140
- 18 Carpenter HA, Tremaine WJ, Batts KP, Czaja AJ. Sequential histologic evaluations in collagenous colitis. Correlations with disease behavior and sampling strategy. Dig Dis Sci 1992; 37 (12) 1903-1909
- 19 Yen EF, Pardi DS. Non-IBD colitides (eosinophilic, microscopic). Best Pract Res Clin Gastroenterol 2012; 26 (5) 611-622
- 20 Chande N, MacDonald JK, McDonald JWD. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009; 104 (1) 235-241 , quiz 234, 242
- 21 Gentile NM, Abdalla AA, Khanna S , et al. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol 2013; 108 (2) 256-259
- 22 Yan BM, Shaffer EA. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009; 58 (5) 721-732
- 23 Okpara N, Aswad B, Baffy G. Eosinophilic colitis. World J Gastroenterol 2009; 15 (24) 2975-2979
- 24 Bates AWH. Diagnosing eosinophilic colitis: histopathological pattern or nosological entity?. Scientifica (Cairo) 2012; 2012: 682576
- 25 Lozinsky AC, Morais MB. Eosinophilic colitis in infants. J Pediatr (Rio J) 2014; 90 (1) 16-21
- 26 Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: an update on pathophysiology and treatment. Br Med Bull 2011; 4 (5) 301-309
- 27 Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: epidemiology, clinical features, and current management. Ther Adv Gastroenterol 2011; 4 (5) 301-309
- 28 Klein N, Hargrove RL, Sleisenger M, Jeffries G. Eosinophilic gastroenteritis. Medicine (Baltimore) 1970; 49 (4) 299-319
- 29 Pardi DS. Miscellaneous colitides. Curr Opin Gastroenterol 2012; 28 (1) 76-81
- 30 Kweon M-N, Yamamoto M, Kajiki M, Takahashi I, Kiyono H. Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J Clin Invest 2000; 106 (2) 199-206
- 31 Shin WG, Park CH, Lee YS , et al. Eosinophilic enteritis presenting as intussusception in adult. Korean J Intern Med 2007; 22 (1) 13-17
- 32 Blackshaw AJ, Levison DA. Eosinophilic infiltrates of the gastrointestinal tract. J Clin Pathol 1986; 39 (1) 1-7
- 33 Lowichik A, Weinberg AG. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol 1996; 9 (2) 110-114
- 34 Shifflet A, Forouhar F, Wu GY. Eosinophilic digestive diseases: eosinophilic esophagitis, gastroenteritis, and colitis. J Formos Med Assoc 2009; 108 (11) 834-843
- 35 Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131 (6) 1981-2002
- 36 Catassi C, Gatti S, Fasano A. ‘The New Epidemiology of Celiac Disease’. J Pediatr Gastroenterol Nutr 2014; 59 (Suppl. 01) S7-9
- 37 Green PHR, Cellier C. Celiac disease. N Engl J Med 2007; 357 (17) 1731-1743
- 38 Norris JM, Barriga K, Hoffenberg EJ , et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005; 293 (19) 2343-2351
- 39 Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA ; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013; 108 (5) 656-676 , quiz 677
- 40 Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for treatment of microscopic colitis. Gastroenterology 1998; 114 (1) 29-36
- 41 Madisch A, Miehlke S, Eichele O , et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis 2007; 22 (12) 1445-1451
- 42 Wildt S, Munck LK, Vinter-Jensen L , et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006; 12 (5) 395-401
- 43 Calabrese C, Fabbri A, Areni A, Zahlane D, Scialpi C, Di Febo G. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol 2007; 22 (6) 809-814
- 44 Baert F, Schmit A, D'Haens G , et al; Belgian IBD Research Group; Codali Brussels. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122 (1) 20-25
- 45 Miehlke S, Heymer P, Bethke B , et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002; 123 (4) 978-984
- 46 Bonderup OK, Hansen JB, Birket-Smith L, Vestergaard V, Teglbjaerg PS, Fallingborg J. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003; 52 (2) 248-251
- 47 Munck LK, Kjeldsen J, Philipsen E, Fischer Hansen B. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol 2003; 38 (6) 606-610